Askpot
← Market research

Psychedelic Therapy (Psilocybin-Assisted Services) — Europe market analysis

The global psychedelic therapy market is in an early growth phase, with North America leading due to progressive regulatory changes and clinical adoption. Psilocybin-assisted therapy is gaining traction for treatment-resistant depression, PTSD, and end-of-life anxiety, but remains largely restricted to clinical trials or pilot programs outside select US states. Market expansion is closely tied to evolving legal frameworks, clinical evidence, and public acceptance.

Market

Psychedelic Therapy (Psilocybin-Assisted Services)

Region

Europe

Growth
CAGR 2019 2024

7.8

CAGR 2024 2030 Base

9.1

CAGR 2024 2030 Downside

4

Drivers

Pilot programs in the UK, Netherlands, and Switzerland; increasing research funding; advocacy for mental health innovation.

Risks

Strict regulatory barriers; slow reimbursement adoption; fragmented policy landscape.

Distribution
Market Size

324000000

Share

18

Footnotes
line1

1) Market size includes legal and regulated psilocybin-assisted therapy services and clinical trial-related revenues; excludes illicit and unregulated use.

line2

2) Growth projections assume continued regulatory progress in North America and Oceania; downside scenario reflects potential policy reversals or slower adoption.

source

Askpot AI Analysis Report 2025